Bill Robinson
InvestorChief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Stanford
Find your path to Bill
29 people in our graph share verified history with Bill — schools, employers, funds. One of them is your warm intro.
About
Dr. Robinson is the James Raitt Professor and Chief of the Division of Immunology and Rheumatology at Stanford University, where his laboratory studies the role of EBV and other microbes in autoimmune diseases including lupus, rheumatoid arthritis, and multiple sclerosis. He has been elected to the Association of American Physicians and the American Society of Clinical Investigation and is an inventor on twenty-one patent applications. He co-founded EBVio and earned his BS, MD, and PhD from Stanford University, completing internal medicine training at UCSF.
Invests in
Biotech
Investments
Investor
EBVio
Per the firm's website.
Colleagues at Red Tree Venture
Frequently asked questions
- Who is Bill Robinson?
- Dr. Robinson is the James Raitt Professor and Chief of the Division of Immunology and Rheumatology at Stanford University, where his laboratory studies the role of EBV and other microbes in autoimmune diseases including lupus, rheumatoid arthritis, and multiple sclerosis. He has been elected to the Association of American Physicians and the American Society of Clinical Investigation and is an inventor on twenty-one patent applications. He co-founded EBVio and earned his BS, MD, and PhD from Stanford University, completing internal medicine training at UCSF.
- Where does Bill Robinson work?
- Bill Robinson is Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture.
- What does Bill Robinson invest in?
- Bill Robinson invests in Biotech.
- What companies has Bill Robinson invested in?
- Investments tracked here include EBVio.